Vanguard Group Inc Nexalin Technology, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 159,878 shares of NXL stock, worth $150,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,878
Previous 159,878 -0.0%
Holding current value
$150,285
Previous $311,000 49.2%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$1.91 - $3.72 $65,738 - $128,034
34,418 Added 27.43%
159,878 $311,000
Q4 2024

Feb 11, 2025
BUY
$0.62 - $4.36 $58,081 - $408,444
93,680 Added 294.78%
125,460 $345,000
Q2 2024

Aug 13, 2024
BUY
$0.61 - $2.96 $19,385 - $94,068
31,780 New
31,780 $53,000

Others Institutions Holding NXL

# of Institutions
22
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Nexalin Technology, Inc.

NXL Quotes by TradingView
  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $6.84M
More about NXL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email